ArticleRadiation oncology (London, England)2022

Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal study.

Hideomi Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.